Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CalciMedica Inc CALC

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.


NDAQ:CALC - Post by User

Comment by Goldy63on May 18, 2022 10:43am
166 Views
Post# 34692191

RE:RE:RE:RE:RE:Graycliff Intersects 5M Gold Grading 6.23 g/t at Shakespeare

RE:RE:RE:RE:RE:Graycliff Intersects 5M Gold Grading 6.23 g/t at Shakespeare
stockman2021 wrote: The only "hole" I see around here are the ones in your head buying the krap you do. 
Troll Gray and yup SGN will do well . Oh troll!!! yup up 26% eat it troll. .$0.0950.02 | 26.67%Bid: 0.085 x 7000Ask: 0.095 x 20000Volume: 131,001
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities